Lv61
2660 积分 2021-12-16 加入
Evaluation of Inclusion and Exclusion Criteria for Pyoderma Gangrenosum in Clinical Research: A Systematic Review
8天前
已完结
Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosum
8天前
已完结
Bimekizumab for The Treatment of Psoriasis
10天前
已完结
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
15天前
已完结
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
27天前
已完结
Epidemiology, comorbidities and mortality of pyoderma gangrenosum: new insights
30天前
已完结
Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases
30天前
已完结
The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum
30天前
已完结
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum
30天前
已完结
Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis
30天前
已完结
皖公网安备34019202002308
